These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 25416141
1. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. Amenta PS, Jallo JI, Tuma RF, Hooper DC, Elliott MB. J Neuroinflammation; 2014 Nov 22; 11():191. PubMed ID: 25416141 [Abstract] [Full Text] [Related]
2. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Zarruk JG, Fernández-López D, García-Yébenes I, García-Gutiérrez MS, Vivancos J, Nombela F, Torres M, Burguete MC, Manzanares J, Lizasoain I, Moro MA. Stroke; 2012 Jan 22; 43(1):211-9. PubMed ID: 22020035 [Abstract] [Full Text] [Related]
8. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy. Szczesniak AM, Porter RF, Toguri JT, Borowska-Fielding J, Gebremeskel S, Siwakoti A, Johnston B, Lehmann C, Kelly ME. Neuropharmacology; 2017 Feb 22; 113(Pt B):627-638. PubMed ID: 27569993 [Abstract] [Full Text] [Related]
9. A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats. Li L, Tao Y, Tang J, Chen Q, Yang Y, Feng Z, Chen Y, Yang L, Yang Y, Zhu G, Feng H, Chen Z. Transl Stroke Res; 2015 Dec 22; 6(6):467-77. PubMed ID: 26376816 [Abstract] [Full Text] [Related]
10. Time-Dependent Protection of CB2 Receptor Agonist in Stroke. Yu SJ, Reiner D, Shen H, Wu KJ, Liu QR, Wang Y. PLoS One; 2015 Dec 22; 10(7):e0132487. PubMed ID: 26186541 [Abstract] [Full Text] [Related]
13. Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents. Jordan CJ, Feng ZW, Galaj E, Bi GH, Xue Y, Liang Y, McGuire T, Xie XQ, Xi ZX. Neuropharmacology; 2020 Oct 01; 176():108241. PubMed ID: 32712273 [Abstract] [Full Text] [Related]
17. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice. Tai S, Vasiljevik T, Sherwood AM, Eddington S, Wilson CD, Prisinzano TE, Fantegrossi WE. Drug Alcohol Depend; 2018 Nov 01; 192():285-293. PubMed ID: 30300803 [Abstract] [Full Text] [Related]
18. Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors. Powers MS, Breit KR, Chester JA. Alcohol Clin Exp Res; 2015 Dec 01; 39(12):2438-46. PubMed ID: 26756798 [Abstract] [Full Text] [Related]
19. CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice. Wu Q, Ma Y, Liu Y, Wang N, Zhao X, Wen D. Life Sci; 2020 Nov 01; 260():118424. PubMed ID: 32949586 [Abstract] [Full Text] [Related]